Chondromyxoid fibroma of the sternum  by Takao, Eiryu et al.
2. Williams DB, Pluth JR, Orszulak TA. Extrinsic obstruction of the
Bjork-Shiley valve in the mitral position. Ann Thorac Surg. 1981;32:
58-62.
3. Trites PN, Kiser JC, Johnson C, Tycast FJ, Gobel FL. Occlusion of
Medtronic Hall mitral valve prosthesis by ruptured papillary muscle and
chordae tendineae. J Thorac Cardiovasc Surg. 1984;88:301-2.
4. Mok CK, Cheung DL, Chiu CS, Aung-Khin M. An unusual lethal
complication of preservation of chordae tendineae in mitral valve re-
placement. J Thorac Cardiovasc Surg. 1988;95:534-6.
5. Lemke P, Roth M, Kraus B, Hohe S, Klovekorn WP, Bauer EP.
Ruptured papillary muscle after mitral valve replacement with preser-
vation of chordae tendineae. Ann Thorac Surg. 2001;72:1384-6.
Chondromyxoid fibroma of the sternum
Eiryu Takao, MD,a Hideo Morioka, MD, PhD,a Hiroo Yabe, MD, PhD,a Ukei Anazawa, MD,a Takeshi Morii, MD, PhD,a
Hirohisa Horinouchi, MD, PhD,b Junichi Shiraishi, MD, PhD,c Makio Mukai, MD, PhD,c Eiichi Sato, MD, PhD,d
Yoshiki Hamada, MD, PhD,d and Yoshiaki Toyama, MD, PhD,a Tokyo and Yamanashi, Japan
Chondromyxoid fibroma (CMF) was described by Jaffeand Lichtenstein1 in 1948 and is thought to be a rarebenign bone tumor, representing less than 1% of thetotal number of primary bone tumors.2 It predomi-
nantly affects the long bones and rarely occurs in the sternum. In
this communication we report a case of CMF of the sternum with
a brief review of the literature.
Clinical Summary
The patient was a 17-year-old man whose chief complaint was
pain in the anterior part of the chest. He had occasionally experi-
enced anterior chest pain since about August 2000 and had con-
sulted a local physician because the pain was aggravated by a fall
in June 2002. A plain x-ray examination had revealed a bone tumor
in the sternum. The patient was first referred to us in July 2002,
and he was admitted for surgery in September 2002. During the
initial physical examination, a tender swelling that was mildly
warm to palpation was found in the middle of the lower sternum.
A plain x-ray film showed an eccentrically located multilobular
radiolucency with mild calcification in the lower sternum. Com-
puted tomography revealed an osteolytic lesion with discrete cal-
cification in the bone marrow of the sternum (Figure 1, A). The
lesion was visualized as an isointense area by T1-weighted mag-
netic resonance imaging and as a well-marginated high-intensity
area by T2-weighted magnetic resonance imaging with a slightly
lobular pattern (Figure 1, B). On the gadolinium-enhanced T1-
weighted image the tumor was well enhanced. On the basis of
these findings, a malignant cartilaginous tumor of the sternum was
suspected, and a biopsy of the lesion was obtained.
Histologic examination of the biopsy specimen revealed a
slightly lobular architecture composed of myxoid matrix populated
by stellate or elongate cells with eosinophilic cytoplasmic pro-
cesses. These myxoid areas were interspersed in a background of
more cellular regions containing dilated sinusoidal vessels and
focal hemorrhage. These findings were compatible with CMF
because there were practically no mitotic figures and the cellular
atypia was minimal (Figure 2, A and B). On the basis of these
histologic findings, the following surgical procedure was per-
formed. A part of the cortex was removed from the anterior surface
of the sternum. The lesion in the bone marrow was completely
curetted, and the remaining lesion was ground off with an air drill.
The space after curettage was completely filled with bone allograft
fragments. The histologic diagnosis of the surgical specimen was
CMF as suspected from the biopsy. The patient’s clinical course
has been uneventful with no local recurrence thus far, 3 years
6 months postoperatively.
Discussion
CMF is the least common benign cartilaginous tumor, and only
106 cases were registered in the Japanese Bone Tumor Registry in
the 21 years from 1972 to 1993.3 It accounts for 0.45% of all
primary bone tumors. The most prevalent site is the metaphysis of
long bone, and the affected sites reported have been the tibia in 33
cases (31%), the femur in 23 cases (22%), and the humerus in 9
cases (8.5%). During the above period, 71 cases of sternal primary
bone tumors were reported, including 18 cases of osteochondroma,
15 cases of chondrosarcoma, and 14 cases of chondroma. Among
these tumors, particular caution is required to differentiate chon-
drosarcoma from CMF. Because of the presence of pleomorphic
cells with hyperchromatic nuclei, the histologic diagnosis of CML
may sometimes be difficult and an erroneous diagnosis of chon-
drosarcoma may result.
To the best of our knowledge, there have been no reports of CMF
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of the sternum in Japan. Since we found only 5 reports in other
countries,4 this is the sixth case reported worldwide in the English
literature. Although en bloc removal was performed in some of the
previous cases to decrease the local recurrence rate,4 good results of
curettage and bone allograft implantation were reported by Lersundi
and associates5 in other lesions. Therefore, we performed complete
curettage of the lesion using an air drill and filled the space with bone
allograft fragments after curettage. There has been no local recurrence
to date, 3 years 6 months postoperatively. This surgical method seems
to be a good option in the treatment of CMF, even in the sternum, to
preserve the thoracic bone structure.
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Figure 1. A, Computed tomography revealed an osteolytic lesion with discrete calcification in the bone marrow of
the sternum. B, On magnetic resonance imaging, the tumor was visualized as a well-marginated high-intensity
area with a slightly lobular pattern in the T2-weighted image.
Figure 2. Histologic examination (hematoxylin and eosin stain). A, The slightly lobular architecture composed of
myxoid matrix populated by stellate or elongate cells. The myxoid areas were interspersed in a background of
more cellular regions containing dilated sinusoidal vessels and focal hemorrhage (original magnification 100).
B, There were practically no mitotic figures and cellular atypia was minimal (magnification, 200).
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